Herbert Smith Freehills advised SF Holding on the deal, while Clifford Chance advised the underwriters. S.F. Holding Co., Ltd. completed its global offering and listing on...
S.F. Holding’s $750 Million IPO On HKSE
Mobvoi Inc.’s IPO on Hong Kong Stock Exchange
Clifford Chance has advised the joint sponsors CICC and CMBI on the deal. Mobvoi Inc. has completed the initial public offering and listing on the Main Board...
Sichuan Baicha Baidao Industrial Co., Ltd. (ChaPanda)’s $330 Million IPO On HKSE
Clifford Chance acted as the legal advisors to the sole sponsor CICC and underwriters. Sichuan Baicha Baidao Industrial Co., Ltd. (ChaPanda) completed the US$330 Million IPO...
Sunshine Insurance’s HK$6.7 Billion IPO
Linklaters and King & Wood Mallesons advised the joint sponsors and underwriters in connection with the offering. Clifford Chance advised Beijing-based Sunshine Insurance Group. China’s Sunshine...
Zhihu’s US$106 Million Hong Kong IPO and Dual Primary Listing
Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisers to Zhihu as to Hong Kong and US laws and Han Kun Law Offices as...
Arrail Group Limited’s US$88 Million Initial Public Offering
Harneys acted as British Virgin Islands and Cayman Islands counsel for the successful listing of the shares of Arrail Group Limited on the Main Board of...
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
Zylox-Tonbridge’s US$330 Million IPO and Listing on the Hong Kong Stock Exchange
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
Bilibili Inc.’s $2.6 Billion Secondary Listing
Walkers acted as Cayman Islands counsel to Bilibili Inc. in connection with its US$2.6 billion global offering of 25 million shares on the Main Board of...
SciClone Pharmaceuticals’ Hong Kong Initial Public Offering And Listing
Clifford Chance, Maples and Calder JunHe advised SciClone Pharmaceuticals on its US$281 million initial public offering and listing on the main board of the Hong Kong...
JD.com’s US$3.87 Billion Hong Kong IPO And Secondary Listing
Clifford Chance has advised the joint sponsors Bank of America, UBS and CLSA, and the underwriters on JD.com’s US$3.87 billion initial public offeringand secondary listing on...